Sen-Jam Pharmaceutical
[Closed for Investment] Sen-Jam Pharmaceutical, with a valuation of $70 million, is raising funds on StartEngine. The pharmaceutical company makes highly accessible, safe, and affordable drugs that work. The drugs of Sen-Jam Pharmaceutical combine NSAIDs and antihistamines to prevent inflammation and associated pain. Sen-Jam Pharmaceutical is majorly targeting opioid withdrawal, alcohol hangover prevention, and COVID-19 therapeutic. Jim Iversen and Jackie Iversen founded Sen-Jam Pharmaceutical in August 2017. The current crowdfunding campaign has a minimum target of $9,996 and a maximum target of $3,992,791.95. The campaign proceeds will be used to complete the COVID Phase II trial, seek emergency use authorization, complete the Phase II trial for the alcohol hangover product, and begin the Phase II trial for opioid withdrawal.
Investment Overview
Raised: $312,093
Deal Terms
Total Commitments ($USD)
- Platform
- StartEngine
- Start Date
- 10/13/2022
- Close Date
- 01/11/2023
$9,996
$3,992,792
$588
Equity - Common
Seed
RegCF
$7.35
$69,979,019
Company & Team
Company
- Year Founded
- 2017
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2C
- Margin
- Medium
- Capital Intensity
- Low
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Ratings 
Company Funding & Growth
Funding history
- Total Prior Capital Raised
- $2,031,016
- VC Backed?
- No
| Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 01/17/2025 | Wefunder | $80,000,000 | $2,668,413 | Convertible Note | Active | RegCF / RegD 506(c) |
| 01/06/2024 | Self Managed | - | - | Convertible Note | Funded | RegD 506(c) |
| 01/11/2023 | StartEngine | $69,979,019 | $312,093 | Equity - Common | Funded | RegCF |
| 07/31/2022 | Wefunder | $25,000,000 | $1,008,951 | Convertible Note | Funded | RegCF |
Growth Charts
Revenue History
Note: Revenue data points reflect the latest of either the most recent fiscal year's financials, or updated revenues directly from the founder, at each raise's close date.
Valuation History
Price per Share History
Note: Share prices shown in earlier rounds may not be indicative of any stock splits.